pentoxyverine bromide

Pentoxyverine bromide is a non-opioid antitussive small molecule being developed as an inhaled aerosol for the treatment of chronic obstructive pulmonary disease (COPD). It primarily functions as a sigma-1 receptor agonist and a muscarinic acetylcholine receptor antagonist. While traditionally used orally for cough suppression, the aerosolized formulation by Chengdu List Pharmaceutical aims to leverage its bronchodilatory and antitussive properties directly in the airways to manage symptoms in patients with mild to moderate stable COPD. Its mechanism involves the inhibition of the cough reflex and potentially bronchodilation through its muscarinic antagonist activity.

Other names

carbetapentane bromide